ADVFN US – Market Content Editor
-
Novartis Secures Positive EU Backing for SMA Gene Therapy Itvisma
Novartis (NYSE:NVS) said the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a favourable opinion recommending approval of Itvisma, an intrathecal gene therapy for spinal muscular atrophy (SMA). The recommendation covers use in children aged two and above, as well as adolescents and adults with 5q SMA carrying a bi-allelic mutation…
-
Nano Labs and ALT5 Sigma Explore AI Data Center Partnership in North America
Nano Labs Ltd (NASDAQ:NA) and ALT5 Sigma Corporation (NASDAQ:ALTS) have signed a non-binding memorandum of understanding to assess a potential partnership focused on AI data centers, agent-based cloud platforms and AI-driven payment systems across North America. The agreement sets out a 90-day review period during which both companies will examine the technical and commercial viability…
-
Tesla Begins Cybercab Production as Robotaxi Strategy Advances
Tesla (NASDAQ:TSLA) has started production of its Cybercab, a fully autonomous robotaxi built without a steering wheel, chief executive Elon Musk said on Friday. The Cybercab marks a strategic move toward a dedicated self-driving ride-hailing platform. Designed specifically for autonomous use, the vehicle does not include conventional driver controls. Tesla shares rose 0.7% in premarket…
-
Newmont Beats Q1 Estimates as Record Cash Flow Drives Buyback Expansion
Newmont Corporation (NYSE:NEM) reported first-quarter results ahead of expectations, with adjusted earnings per share of $2.90 topping forecasts by $0.72 and revenue of $7.31 billion exceeding the $6.53 billion consensus. Despite the strong results, shares were slightly lower in premarket trading on Friday. Record Cash Flow and Strong Gold Prices The world’s largest gold miner…
-
Intel Soars in Premarket After Blowout Results, Eyes Record High
Shares of Intel Corp (NASDAQ:INTC) surged about 28% in premarket trading on Friday after the chipmaker delivered stronger-than-expected first-quarter results and issued an upbeat outlook for the second quarter, driven by robust demand for its AI-focused data center chips. The stock climbed to around $85, putting it on track to surpass its all-time high reached…
-
Oil Advances on Fears of Escalating Middle East Conflict
Oil prices moved higher on Friday amid growing concerns that military tensions in the Middle East could intensify, after Iran released footage showing commandos boarding a cargo vessel in the Strait of Hormuz and reports emerged that its air defence systems had engaged “hostile targets.” Brent crude futures climbed 99 cents, or 0.94%, to $106.06…
-
Gold Heads for Weekly Drop as Dollar Strength Weighs Amid U.S.-Iran Tensions
Gold prices declined on Friday and were on track for a notable weekly loss, as heightened uncertainty surrounding the U.S.-Iran conflict drove investors toward the dollar. Spot gold slipped 0.5% to $4,672.22 an ounce by 02:27 ET (06:27 GMT), while gold futures fell 0.8% to $4,686.89 per ounce. Over the week, spot prices were set…
-
Markets Drift as Oil Stays Elevated and Intel Jumps: Dow Jones, S&P, Nasdaq, Wall Street Futures
Futures tied to major U.S. indices were mixed on Friday, hovering around flat levels, while oil prices held above $100 per barrel as disruptions in the Strait of Hormuz persisted despite a fragile U.S.-Iran ceasefire. Meanwhile, shares of Intel (NASDAQ:INTC) surged in after-hours trading following an upbeat outlook from the chipmaker. Futures Struggle for Direction…
-
Software Selloff and Rising Oil Prices Pull Wall Street Back from Record Highs
U.S. stocks retreated on Thursday as a sharp selloff in software shares and surging crude oil prices gave investors reason to book profits after the previous session’s rally to all-time highs. The S&P 500 had just notched a fresh record on Wednesday following President Trump’s extension of the ceasefire with Iran, but optimism faded quickly…
-
Canopy Growth jumps as U.S. moves to ease medical marijuana restrictions
Shares of cannabis companies rallied in premarket trading on Thursday after a major regulatory shift in the United States signaled a more favorable environment for the sector, with Canopy Growth Corp (NASDAQ:CGC) among the notable gainers. The move follows news that the acting U.S. attorney general signed an order to reclassify state-licensed medical marijuana, shifting…